An Oakland-based startup called Omicia has raised a $6.8 million series A round of venture capital, led by Artis Ventures, for a cloud service that lets doctors analyze whole human genomes in order to identify the presence of diseases. The basic service is free (while more-advanced analyses and capabilities cost $99), and the whole process takes less than 3 hours for a whole genome (or less than 1 hour for an exome). Advances in sequencing, algorithms, data storage and cloud computing have been rapidly driving down the cost of genomic analysis over the past few years, leading to an uptick of of startup activity in the space.
The market for data center switching has changed dramatically over the last decade due to the consolidation of data center operations into…Read More
This free 1-hour webinar from GigaOm Research brings together experts in data management, featuring GigaOm analyst William McKnight and a special guest…Watch Now
Apex America, a customer experience (CX) services company headquartered in Latin America, needed to expand its capacity rapidly. It used Google’s cloud-based…Read More
The supply of artificial intelligence (AI) accelerator processors for edge computing is a market estimated to be currently worth some $20 billion…Read More
It is no news that enterprises are adopting fresh hybrid cloud strategies—and by hybrid we mean multi-cloud approaches that can blend multiple…Read More